Codexis Raises $78 Million in IPO

Codexis Inc., a Redwood City, Calif.-based provider of solutions for pharma chemical process development and manufacturing, raised around $78 million via its IPO. The company priced six million shares being offered at $13 per share, or the low end of its $13-$15 per share range. The company’s initial market cap is approximately $441 million.

It will trade on the Nasdaq under ticker symbol CDXS, while Credit Suisse served as lead underwriter.

Codexis reported product revenue of $18.55 million in 2009 revenue, up from $16.86 million in 2008.

Codexis had raised just over $80 million in VC funding since 2002, from firms like CCTV Investments, CMEA Ventures, Pequot Capital, Bio*One Capital and Pfizer. It canceled a previous $100 million IPO attempt in September 2008.

Leave a Reply

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget